查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944426

全球藥品噴霧乾燥市場：依產品類型、乾燥方法、應用、最終用戶、國家及地區分類－產業分析、市場規模、佔有率及未來預測（2025-2032年）

Pharmaceutical Spray Drying Market, By Product Type, By Drying Configuration, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 352 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，醫藥噴霧乾燥市場規模將達到 21.303 億美元，並預計從 2025 年到 2032 年將以 7.50% 的複合年成長率成長。

藥物噴霧乾燥市場專注於利用噴霧乾燥技術將液態藥物成分（例如溶液、懸浮液和乳液）轉化為乾燥、流動性良好的粉末，並可控制其粒徑、形狀、密度、水分或殘留溶劑含量。在藥物研發和生產中，噴霧乾燥被廣泛認為不僅僅是一種乾燥工藝，因為它能夠實現顆粒設計，從而達到特定的性能目標。當傳統製程無法獲得所需的粉末特性時，噴霧乾燥通常是首選方法，尤其適用於水溶性差的化合物、不穩定的活性成分以及需要精確控制溶解度和分散性的製劑。

這一市場成長與難溶性小分子候選藥物的增加、對非晶質固體分散體等製劑技術的需求，以及吸入和鼻腔給藥製劑的穩定擴張密切相關，在這些製劑中，動態粒徑是一項關鍵的品質屬性。該技術的應用還包括掩味、控釋、穩定敏感活性成分，以及提高下游製程（如混合、包封和壓片）的可製造性。研發和製程開發團隊重視這項技術，因為它能夠快速篩檢製劑、基於參數可預測地調節顆粒特性，並透過對製程的深入理解和品質源於設計 (QbD) 框架，為規模化生產提供清晰的路徑。

醫藥噴霧乾燥市場動態

難溶性新藥數量的增加和活躍的核准週期推動了噴霧乾燥技術在製劑實現中的應用。

推動藥物噴霧乾燥市場發展的關鍵因素是新藥認證的持續成長以及解決水溶性差的分子問題的需求日益成長。低溶解度會導致吸收率低且不穩定，迫使製劑團隊採用有效的策略，例如噴霧乾燥非晶質固體分散體和精確設計的乾粉。近期核准的數量也反映了研發工作的規模：根據美國食品藥物管理局）的數據，2021年核准50種新分子實體（NME），2022年37種，2023年55種，2024年50種，2022年37種，2023年55種，2024年50種，2021年這種情況持續迫使研發和生產團隊儘早選擇可擴展的製程。生產團隊也面臨儘早選擇可擴展製程的壓力。在研發管線層面，臨床試驗的工作量仍然很大，而且仍在進行中。根據美國國立衛生研究院 (NIH) 下屬的美國國家醫學圖書館 (NLM) 的 ClinicalTrials.gov 網站的數據，該註冊庫包含數十萬項已註冊的研究，其中數萬項正在進行或正在招募患者，這表明廣泛的項目最終都需要進行配方最佳化和技術轉移。在生產方面，對可靠且可重複的生產流程的需求推動了對顆粒工程和乾燥技術的投資。根據美國人口普查局估計，2020 年代初期的行業出貨收益將達到數千億美元，因此，即使收率、批間均勻性和週期時間的適度改進也能顯著降低成本並提高供應安全性。活躍的核准流程、大規模的臨床研發管線和高價值的生產產出，這些因素共同意味著標準的結晶和研磨方法已不再適用，噴霧乾燥成為在符合 GMP 要求的前提下控制顆粒性質、提高溶解度和降低放大生產風險的可行選擇。

藥物噴霧乾燥市場：細分分析

隨著開發平臺的持續活躍，許多藥物項目需要專業的GMP設施、溶劑處理以及快速的技術轉移（無需等待新的內部設備），合約噴霧乾燥和加工服務正日益受到關注。根據ClinicalTrials.gov（美國國立衛生研究院下屬國家醫學圖書館）的數據，該資料庫在2020年代已註冊的臨床試驗數量顯著成長至超過40萬項，近年來還有數萬項試驗被列為「進行中」或「招募中」。這顯示製劑和製程開發工作正穩步推進研發階段。這項工作與商業化準備直接相關，因為每個成功的專案最終都需要一條可擴展且有據可查的生產路線。根據美國食品藥物管理局（FDA）藥物評估與研究中心（CDER）的數據，預計2021年新分子實體（NME）核准將達到50個，2022年為37個，2023年為55個，2024年為50個，2021年至2024年累計。如此高的核准數量給生產商和合約合作夥伴帶來了持續的壓力，他們需要建立相關製程、進行驗證並支援產品上市，其中噴霧乾燥技術經常被考慮，尤其是在顆粒設計和粉末品質穩定性方面。

製藥生產也支撐著噴霧乾燥技術的需求。商業化生產高度重視批次間的一致性、可預測的粉末流動性以及對下游製程（如混合、填充、膠囊封裝、壓片和吸入裝置性能）中顆粒特性的控制。根據美國人口普查局（《藥品和準藥品製造業統計》，北美行業分類系統代碼 3254）的數據，2020 年代初美國該行業的出貨收益預計達數千億美元，這表明即使是產量、週期時間和偏差方面的大規模工藝改進，也能在規模化生產中產生顯著的經濟影響。同時，美國食品藥物管理局 (FDA) 藥品評估與研究中心 (CDER) 的年度藥品核准報告指出，2020 年至 2024 年間新藥的持續核准為生命週期生產活動（如規模化生產、核准後製程改良和備用供應商規劃）提供了支持。所有這些都有利於採用穩健且可重複的粉末加工方法，例如噴霧乾燥，因為產品性能取決於嚴格的顆粒控制。

醫藥噴霧乾燥市場—區域分析

藥物噴霧乾燥的需求往往集中在藥物研發活動持續活躍且GMP生產規模較大的地區。這是因為噴霧乾燥技術通常在產品線已具備規模化生產和商業化供應條件時才會被採用。根據美國FDA藥物評估與研究中心（CDER）的數據，預計2021年核准的新分子實體將達到50種，2022年為37種，2023年為55種，2024年為50種，2021年至2024年累計獲批192種。這表明，需要可直接用於生產的製劑和受控粉末加工的產品供應穩定。歐洲藥品管理局（EMA）表示，該機構預計在2020年代初期仍將保持較高的評估和核准水平，這支撐了歐洲對先進加工技術的持續需求，因為歐洲對合規性和文件要求較高。在亞洲，隨著受監管的生產和出口導向生產的成長，投資可能會隨之增加。根據世界衛生組織 (WHO) 在 2020 年代初期發布的關於加​​強監管體系的出版物，越來越多的國家正在努力提高其監管能力的成熟度，這通常會支持更廣泛地採用符合 GMP 標準的技術和專業的契約製造。

美國藥品噴霧乾燥市場—國家分析

鑑於其核准數量、臨床活動和大規模生產的經濟效益，美國是最具潛力的單一國家市場。根據美國食品藥物管理局（FDA）藥物評估與研究中心（CDER）的數據，2021年至2024年新分子（NME）的核准速度依然強勁，年核准分別為50種、37種、55種及50種。這推動了積極的產品上市計劃和全生命週期生產運營，並促使企業投資可擴展的顆粒工程工藝，例如噴霧乾燥。研發深度依然顯著。根據ClinicalTrials.gov（美國國立衛生研究院下屬的美國國家醫學圖書館）的數據，2020年代註冊的臨床試驗總數已超過40萬項，近年來還有大量「正在進行」或「正在招募」的試驗，這支撐了對製劑開發和製程最佳化的持續需求。此外，美國的生產基礎設施規模龐大，即使是微小的效率提升也能產生顯著的影響。美國人口普查局（藥品和準藥品製造，NAICS 3254）報告稱，2020 年代初期的出貨收益數千億美元，這凸顯了產量比率、批次間一致性、密封性能和溶劑處理能力為何是設備和外包服務的實用採購標準。

目錄

第1章 製藥噴霧乾燥市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：醫藥噴霧乾燥的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章 醫藥噴霧乾燥市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

5. 醫藥噴霧乾燥市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：藥物噴霧乾燥的市場現狀

  • 醫藥噴霧乾燥市佔分析（2024）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 依產品類型分類的製藥噴霧乾燥市場

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 噴霧乾燥機（設備）
    • 配件和耗材
    • 服務（合約噴霧乾燥/加工）

8. 依乾燥方法分類的藥物噴霧乾燥市場

  • 概述
    • 細分市場佔有率分析：按乾燥法
    • 正向流動類型
    • 逆流式
    • 混合流

9. 按應用分類的製藥噴霧乾燥市場

  • 概述
    • 細分市場佔有率分析：按應用
    • API（原料藥）
    • 添加劑
    • 製劑形式（例如，吸入劑、口服固體製劑）

第10章：以最終用戶分類的製藥噴霧乾燥市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 製藥和生物製藥公司
    • 合約研發生產組織（CDMO/CMO）
    • 研究機構和實驗室

11. 各地區醫藥噴霧乾燥市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析－製藥噴霧乾燥產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • BUCHI Labortechnik AG
    • Catalent, Inc.
    • Dedert Corporation
    • European SprayDry Technologies LLP
    • Fette Compacting GmbH
    • GEA Group Aktiengesellschaft
    • Glatt GmbH
    • GMP Pharmaceuticals, LLC
    • Hovione, SA
    • Labultima
    • Lonza Group AG
    • Merck KGaA
    • New AVM Systech Pvt. Ltd.
    • SiccaDania A/S
    • SPX FLOW, Inc.
    • SUDMO GmbH
    • Swenson Technology, Inc.
    • Tetra Pak International SA
    • Thermo Fisher Scientific Inc.
    • Yamato Scientific Co., Ltd.
    • Others

第13章：分析師視角360度分析

簡介目錄
Product Code: ANV6002

Pharmaceutical Spray Drying Market size was valued at US$ 2,130.30 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.

The pharmaceutical spray drying market focuses on the use of spray drying to turn liquid drug feeds such as solutions, suspensions, or emulsions into dry, free-flowing powders with controlled particle size, shape, density, and moisture or residual solvent levels. In pharmaceutical research and manufacturing, spray drying is widely treated as more than a simple drying step because it can be used to engineer particles for specific performance targets. It is often chosen when conventional processing cannot achieve the required powder properties, especially for compounds with poor water solubility, unstable actives, or formulations that need precise control over dissolution and dispersibility.

Growth in this market is closely linked to the increasing number of poorly soluble small-molecule candidates and the need for enabling formulation approaches such as amorphous solid dispersions, as well as the steady expansion of inhalation and nasal drug products where aerodynamic particle size is a critical quality attribute. Spray drying is also applied for taste masking, controlled release, stabilization of sensitive actives, and improving downstream manufacturability for blending, encapsulation, and tableting. For R&D and process development teams, the technology is valued for rapid formulation screening, predictable parameter-based tuning of particle properties, and a clearer path for scale-up when supported by process understanding and Quality by Design frameworks.

Pharmaceutical Spray Drying Market- Market Dynamics

More Poorly Soluble New Drugs and a Busy Approval Cycle Are Driving Spray Drying for Enabling Formulations

A key driver for the pharmaceutical spray drying market is the steady flow of new drug approvals and the growing need to "fix" molecules that do not dissolve well in water, since poor solubility often leads to low and variable absorption and forces formulation teams to use enabling approaches like spray-dried amorphous solid dispersions or carefully engineered dry powders. The scale of development work is clear in recent approval volumes: According to the U.S. Food and Drug Administration (FDA) CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 NMEs across 2021-2024, which keeps pressure on R&D and manufacturing groups to select scalable processes early. At the pipeline level, the clinical workload remains large and continuous: According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry contains hundreds of thousands of studies overall, with tens of thousands in active or recruiting status in recent years, pointing to a wide base of programs that eventually require formulation optimization and tech transfer. On the production side, demand for reliable, repeatable manufacturing supports investment in particle engineering and drying technologies: According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing), industry shipment values in the early 2020s are reported at hundreds of billions of dollars, meaning small gains in yield, batch consistency, and cycle time can translate into meaningful cost and supply improvements. This combination of a busy approval cycle, a large clinical pipeline, and high-value manufacturing output increases the number of cases where standard crystallization or milling is not enough, making spray drying a practical choice to control particle properties, improve dissolution, and reduce scale-up risk under GMP expectations.

Pharmaceutical Spray Drying Market- Segmentation Analysis:

Outsourced spray drying and processing keeps gaining attention because the development pipeline stays busy and many drug programs need specialized GMP facilities, solvent handling, and fast tech transfer without waiting for new internal capacity. According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the database has grown to well over 400,000 registered studies in the 2020s, with tens of thousands listed as active or recruiting in recent years, which points to a steady stream of formulation and process work moving through R&D. That workload connects directly to commercial readiness, since each successful program eventually needs a scalable and documented manufacturing route. According to U.S. FDA CDER, new molecular entity approvals reached 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, which adds up to 192 NMEs over 2021-2024; this level of approvals keeps pressure on manufacturers and contract partners to lock processes, run validation campaigns, and support launches where spray drying is often considered for particle engineering and consistent powder quality.

Finished dosage manufacturing also supports demand for spray drying because commercial production places high value on batch consistency, predictable powder flow, and controlled particle properties for downstream steps like blending, filling, encapsulation, tableting, or inhalation device performance. According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing, NAICS 3254), U.S. shipment values for this industry are reported in the hundreds of billions of dollars in the early 2020s, showing how even small process gains in yield, cycle time, and deviations can matter financially at scale. Alongside this, according to U.S. FDA CDER annual drug approval reporting, the continuing flow of novel approvals through 2020-2024 supports ongoing lifecycle manufacturing activities such as scale-up, post-approval process changes, and second-source planning, all of which favor robust, repeatable powder-processing methods like spray drying when product performance depends on tight particle control.

Pharmaceutical Spray Drying Market- Geographical Insights

Pharmaceutical spray drying demand tends to concentrate in regions where drug development activity and GMP manufacturing output stay high, because spray drying is usually adopted when a pipeline exists that can move into scale-up and commercial supply. According to U.S. FDA CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 approvals across 2021-2024, which signals a steady flow of products that need manufacturing-ready formulation decisions and controlled powder processing. According to the European Medicines Agency (EMA), the agency continued to publish strong levels of evaluation and authorization activity through the early 2020s, supporting ongoing demand for advanced processing technologies in Europe where compliance and documentation expectations are high. Across Asia, investment tends to follow growth in regulated manufacturing and export-oriented production; according to the World Health Organization (WHO) regulatory system strengthening publications in the early 2020s, more countries have been progressing toward higher maturity regulatory functions, which typically supports broader adoption of GMP-aligned technologies and specialized contract manufacturing capacity.

United States Pharmaceutical Spray Drying Market- Country Insights

The United States looks like the strongest single-country opportunity because it combines approvals, clinical activity, and large-scale manufacturing economics. According to U.S. FDA CDER, the 2021-2024 NME approval run-rate remained high, with annual counts of 50, 37, 55, and 50, which keeps launch timelines and lifecycle manufacturing work active and encourages investment in scalable particle engineering routes such as spray drying. Development depth also remains visible; according to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry includes well over 400,000 studies in total in the 2020s, with a very large number of trials listed as active or recruiting in recent years, which supports continued demand for formulation development and process optimization. The manufacturing base is also large enough for small efficiency improvements to matter; according to the U.S. Census Bureau (pharmaceutical and medicine manufacturing, NAICS 3254), shipment values are reported in the hundreds of billions of dollars in the early 2020s, reinforcing why yield, batch consistency, containment, and solvent-handling capability become practical buying criteria for both equipment and outsourced services.

Pharmaceutical Spray Drying Market- Competitive Landscape:

The competitive landscape usually splits into equipment suppliers focused on lab-to-commercial spray drying systems and CDMOs that offer development plus GMP spray drying as a service, often bundled with analytical testing and regulatory documentation. Commonly referenced equipment vendors include GEA Group Aktiengesellschaft (strong in large-scale system engineering and global service coverage), BUCHI Labortechnik AG (strong in laboratory and pilot tools used in formulation screening and process development), SPX FLOW, Inc. (strong in industrial drying experience and custom builds), Yamato Scientific Co., Ltd. (strong in lab-scale penetration in research environments), and Glatt GmbH (strong in pharmaceutical process equipment engineering and GMP-oriented designs). Commonly referenced service-oriented vendors include Catalent, Inc. (strong in moving programs from development into commercial manufacturing), Lonza Group AG (strong in global GMP manufacturing networks and complex programs), and Hovione, S.A. (strong in particle engineering and enabling formulation work, including inhalation-focused development). In purchasing decisions, the main differentiators tend to be proven scale-up performance, containment level for potent compounds, solvent safety and recovery options, analytical capability for particle and solid-state characterization, and inspection-ready quality systems that reduce technical and regulatory risk.

Recent Developments:

In November 2025, Hovione (a Portugal-based contract development and manufacturing organization, CDMO) completed an initial US$100 million investment round to expand its East Windsor, New Jersey site, taking the footprint to more than 200,000 sq. ft. and more than doubling spray-drying capacity; the first phase adds a 31,000-sq.-ft. building with two size-3 spray dryers (PSD-3) for amorphous solid dispersion (ASD) production, with construction underway and GMP operations targeted for Q2 2026.

In October 2025, Codis (a CDMO formed from the combination of U.S.-based Particle Dynamics and a U.K. spray drying site previously operated by EuroAPI) launched with over 5,000 metric tons per year of spray-drying output capacity, more than 300 employees globally, and 40,000 square meters of manufacturing space across three GMP facilities, positioning the business for commercial-scale ASD, particle engineering, and finished dose manufacturing, while noting seven regulatory approvals achieved.

In September 2024, Seran Bioscience (a CDMO providing development, analytical, and manufacturing services) announced a strategic growth transaction of more than US$200 million led by Bain Capital Life Sciences (with Vivo Capital remaining a key shareholder) to support construction of a new commercial-scale manufacturing facility planned for completion in 2026, expanding integrated capabilities across oral, pulmonary, and nasal delivery with particle-engineering technologies including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, plus finished dose and packaging/serialization; the company cited 200+ team members (including 150+ scientists and engineers) and plans to hire up to 150 additional employees, building toward a nearly 200,000-sq.-ft. campus in Bend, Oregon.

In September 2024, Evonik (a specialty chemicals company and pharmaceutical excipient supplier) opened a new Darmstadt facility for drying aqueous dispersions of EUDRAGIT(R) polymers, described as a double-digit million-euro investment to expand excipient capacity for oral drug delivery, improve supply security and delivery times, and operate with green electricity and steam from local waste incineration, targeting savings of more than 1,000 CO2 equivalents per year and alignment with IPEC-GMP guidelines through direct connection to its EUDRAGIT(R) dispersion production.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BUCHI Labortechnik AG
  • Catalent, Inc.
  • Dedert Corporation
  • European SprayDry Technologies LLP
  • Fette Compacting GmbH
  • GEA Group Aktiengesellschaft
  • Glatt GmbH
  • GMP Pharmaceuticals, LLC
  • Hovione, S.A.
  • Labultima
  • Lonza Group AG
  • Merck KGaA
  • New AVM Systech Pvt. Ltd.
  • SiccaDania A/S
  • SPX FLOW, Inc.
  • SUDMO GmbH
  • Swenson Technology, Inc.
  • Tetra Pak International S.A.
  • Thermo Fisher Scientific Inc.
  • Yamato Scientific Co., Ltd.
  • Others

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Spray Dryers (equipment)
  • Accessories/Consumables
  • Services (contract spray drying/processing)

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY DRYING CONFIGURATION- MARKET ANALYSIS, 2019 - 2032

  • Co-current
  • Counter-current
  • Mixed-flow

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • APIs (active pharmaceutical ingredients)
  • Excipients
  • Finished Dosage Forms (e.g., inhalation, oral solid dosage)

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • Research Institutes & Laboratories

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Spray Drying Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Spray Drying Market Snippet by Product Type
    • 2.1.2. Pharmaceutical Spray Drying Market Snippet by Drying Configuration
    • 2.1.3. Pharmaceutical Spray Drying Market Snippet by Application
    • 2.1.4. Pharmaceutical Spray Drying Market Snippet by End User
    • 2.1.5. Pharmaceutical Spray Drying Market Snippet by Country
    • 2.1.6. Pharmaceutical Spray Drying Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Spray Drying Key Market Trends

  • 3.1. Pharmaceutical Spray Drying Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Spray Drying Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Spray Drying Market Opportunities
  • 3.4. Pharmaceutical Spray Drying Market Future Trends

4. Pharmaceutical Spray Drying Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Spray Drying Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Spray Drying Market Landscape

  • 6.1. Pharmaceutical Spray Drying Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Spray Drying Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Spray Dryers (equipment)
    • 7.1.3. Accessories/Consumables
    • 7.1.4. Services (contract spray drying/processing)

8. Pharmaceutical Spray Drying Market - By Drying Configuration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drying Configuration, 2024 & 2032 (%)
    • 8.1.2. Co-current
    • 8.1.3. Counter-current
    • 8.1.4. Mixed-flow

9. Pharmaceutical Spray Drying Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. APIs (active pharmaceutical ingredients)
    • 9.1.3. Excipients
    • 9.1.4. Finished Dosage Forms (e.g., inhalation, oral solid dosage)

10. Pharmaceutical Spray Drying Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Drying Configuration, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biopharmaceutical Companies
    • 10.1.3. Contract Development & Manufacturing Organizations (CDMOs/CMOs)
    • 10.1.4. Research Institutes & Laboratories

11. Pharmaceutical Spray Drying Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pharmaceutical Spray Drying Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pharmaceutical Spray Drying Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pharmaceutical Spray Drying Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Pharmaceutical Spray Drying Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Pharmaceutical Spray Drying Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pharmaceutical Spray Drying Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. BUCHI Labortechnik AG
    • 12.2.2. Catalent, Inc.
    • 12.2.3. Dedert Corporation
    • 12.2.4. European SprayDry Technologies LLP
    • 12.2.5. Fette Compacting GmbH
    • 12.2.6. GEA Group Aktiengesellschaft
    • 12.2.7. Glatt GmbH
    • 12.2.8. GMP Pharmaceuticals, LLC
    • 12.2.9. Hovione, S.A.
    • 12.2.10. Labultima
    • 12.2.11. Lonza Group AG
    • 12.2.12. Merck KGaA
    • 12.2.13. New AVM Systech Pvt. Ltd.
    • 12.2.14. SiccaDania A/S
    • 12.2.15. SPX FLOW, Inc.
    • 12.2.16. SUDMO GmbH
    • 12.2.17. Swenson Technology, Inc.
    • 12.2.18. Tetra Pak International S.A.
    • 12.2.19. Thermo Fisher Scientific Inc.
    • 12.2.20. Yamato Scientific Co., Ltd.
    • 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us